Literature DB >> 20553055

Recurrence of adverse drug reactions following inappropriate re-prescription: better documentation, availability of information and monitoring are needed.

Carolien M J van der Linden1, Paul A F Jansen, Rob J van Marum, René J E Grouls, Erik H M Korsten, Antoine C G Egberts.   

Abstract

Adverse drug reactions (ADRs) are a common, and often preventable, cause of hospital admission, especially in the elderly, and can occur during hospitalization. In this current opinion article, we present three cases of recurrence of a serious ADR due to re-prescription of a withdrawn medication that highlight the need for a system to prevent the undesirable re-prescription of medications withdrawn because of an ADR. In addition, we describe an electronic system that could help prevent undesirable re-prescription following an ADR. Such a system should document ADRs systematically at the patient level, make this information available to relevant healthcare providers and the patient, and flag re-prescription of the offending drug. The effectiveness and cost effectiveness of such a system would need to be determined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553055     DOI: 10.2165/11532350-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  7 in total

1.  Adverse drug reactions: definitions, diagnosis, and management.

Authors:  I R Edwards; J K Aronson
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

Review 2.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

3.  Represcription after adverse drug reaction in the elderly: a descriptive study.

Authors:  Carolien M J van der Linden; Marieke C H Kerskes; Annemarie M H Bijl; Huub A A M Maas; Antoine C G Egberts; Paul A F Jansen
Journal:  Arch Intern Med       Date:  2006 Aug 14-28

4.  Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.

Authors:  Anne J Leendertse; Antoine C G Egberts; Lennart J Stoker; Patricia M L A van den Bemt
Journal:  Arch Intern Med       Date:  2008-09-22

5.  An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use.

Authors:  M S Kramer; J M Leventhal; T A Hutchinson; A R Feinstein
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study.

Authors:  C K Mannesse; F H Derkx; M A de Ridder; A J Man in 't Veld; T J van der Cammen
Journal:  BMJ       Date:  1997-10-25
  7 in total
  11 in total

Review 1.  Identifying high-risk medication: a systematic literature review.

Authors:  Eva A Saedder; Birgitte Brock; Lars Peter Nielsen; Dorthe K Bonnerup; Marianne Lisby
Journal:  Eur J Clin Pharmacol       Date:  2014-03-27       Impact factor: 2.953

Review 2.  Adverse drug event reporting systems: a systematic review.

Authors:  Chantelle Bailey; David Peddie; Maeve E Wickham; Katherin Badke; Serena S Small; Mary M Doyle-Waters; Ellen Balka; Corinne M Hohl
Journal:  Br J Clin Pharmacol       Date:  2016-05-09       Impact factor: 4.335

3.  Identifying adverse drug reactions from free-text electronic hospital health record notes.

Authors:  Arthur Wasylewicz; Britt van de Burgt; Aniek Weterings; Naomi Jessurun; Erik Korsten; Toine Egberts; Arthur Bouwman; Marieke Kerskes; René Grouls; Carolien van der Linden
Journal:  Br J Clin Pharmacol       Date:  2021-10-13       Impact factor: 3.716

4.  Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design.

Authors:  David Peddie; Serena S Small; Katherin Badke; Maeve E Wickham; Chantelle Bailey; Adam Chruscicki; Christine Ackerley; Ellen Balka; Corinne M Hohl
Journal:  JMIR Res Protoc       Date:  2016-08-18

5.  Methods for evaluating adverse drug event preventability in emergency department patients.

Authors:  Stephanie A Woo; Amber Cragg; Maeve E Wickham; David Peddie; Ellen Balka; Frank Scheuermeyer; Diane Villanyi; Corinne M Hohl
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

6.  Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset.

Authors:  David Peddie; Serena S Small; Katherin Badke; Chantelle Bailey; Ellen Balka; Corinne M Hohl
Journal:  JMIR Med Inform       Date:  2018-06-28

7.  Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial.

Authors:  Jeffrey P Hau; Penelope M A Brasher; Amber Cragg; Serena Small; Maeve Wickham; Corinne M Hohl
Journal:  Trials       Date:  2021-02-05       Impact factor: 2.279

8.  The Utility of Different Data Standards to Document Adverse Drug Event Symptoms and Diagnoses: Mixed Methods Study.

Authors:  Erina Chan; Serena S Small; Maeve E Wickham; Vicki Cheng; Ellen Balka; Corinne M Hohl
Journal:  J Med Internet Res       Date:  2021-12-10       Impact factor: 5.428

9.  A descriptive exploratory study of how admissions caused by medication-related harm are documented within inpatients' medical records.

Authors:  Matthew Reynolds; Mary Hickson; Ann Jacklin; Bryony Dean Franklin
Journal:  BMC Health Serv Res       Date:  2014-06-16       Impact factor: 2.655

10.  Why Clinicians Don't Report Adverse Drug Events: Qualitative Study.

Authors:  Corinne M Hohl; Serena S Small; David Peddie; Katherin Badke; Ellen Balka; Chantelle Bailey
Journal:  JMIR Public Health Surveill       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.